[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2376 Introduced in House (IH)]

112th CONGRESS
  1st Session
                                H. R. 2376

 To amend the Public Health Service Act to provide for human stem cell 
 research, including human embryonic stem cell research, and for other 
                               purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             June 24, 2011

 Ms. DeGette (for herself and Mr. Dent) introduced the following bill; 
       which was referred to the Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
 To amend the Public Health Service Act to provide for human stem cell 
 research, including human embryonic stem cell research, and for other 
                               purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Stem Cell Research Advancement Act 
of 2011''.

SEC. 2. FINDINGS.

    The Congress finds as follows:
            (1) On March 9, 2009, President Barack Obama issued 
        Executive Order 13505, entitled ``Removing Barriers to 
        Responsible Scientific Research Involving Human Stem Cells''.
            (2) On July 7, 2009, the National Institutes of Health 
        issued guidelines on human stem cell research.
            (3) The scientific field of stem cell research is 
        continually advancing.

SEC. 3. HUMAN STEM CELL RESEARCH.

    Part H of title IV of the Public Health Service Act (42 U.S.C. 289 
et seq.) is amended by inserting after section 498D the following:

``SEC. 498E. HUMAN STEM CELL RESEARCH.

    ``(a) In General.--Notwithstanding any other provision of law, the 
Secretary shall conduct and support research that utilizes human stem 
cells, including human embryonic stem cells.
    ``(b) Eligibility.--Human embryonic stem cells eligible for use in 
research under subsection (a) shall include stem cells that meet each 
of the following:
            ``(1) The stem cells were derived from human embryos that 
        have been donated from in vitro fertilization clinics, were 
        created for the purposes of reproductive treatment, and were in 
        excess of the clinical need of the individuals seeking such 
        treatment.
            ``(2) It was determined through consultation with the 
        individuals seeking reproductive treatment that the embryos to 
        be donated would never be implanted in a woman and would 
        otherwise be discarded.
            ``(3) The individuals seeking reproductive treatment 
        donated the embryos with written informed consent and without 
        receiving any financial or other inducements to make the 
        donation.

``SEC. 498F. GUIDELINES.

    ``The Secretary, in consultation with the Director of NIH, shall--
            ``(1) maintain guidelines applicable to the conduct or 
        support of human stem cell research by the Department of Health 
        and Human Services;
            ``(2) review such guidelines not less than every 3 years; 
        and
            ``(3) update such guidelines as scientifically warranted.

``SEC. 498G. PROHIBITION AGAINST FUNDING FOR HUMAN CLONING.

    ``(a) Prohibition.--The Secretary shall not use any funds for the 
conduct or support of human cloning.
    ``(b) Guidelines.--The Secretary shall update the guidelines 
maintained under section 498F for consistency with subsection (a).
    ``(c) Definitions.--In this section, the term `human cloning' means 
the implantation of the product of transferring the nuclear material of 
a human somatic cell into an egg cell from which the nuclear material 
has been removed or rendered inert into a uterus or the functional 
equivalent of a uterus.''.

SEC. 4. REPORTING REQUIREMENTS.

    Section 403(a)(5) of the Public Health Service Act (42 U.S.C. 
283(a)(5)) is amended--
            (1) by redesignating subparagraph (L) as (M); and
            (2) by inserting after subparagraph (K) the following:
                    ``(L) Human stem cells.''.
                                 <all>